80 related articles for article (PubMed ID: 20384981)
1. Abolition of prescription copayments in Wales: an observational study on dispensing rates.
Cohen D; Alam MF; Dunstan FD; Myles S; Hughes DA; Routledge PA
Value Health; 2010 Aug; 13(5):675-80. PubMed ID: 20384981
[TBL] [Abstract][Full Text] [Related]
2. Impact of the phased abolition of co-payments on the utilisation of selected prescription medicines in Wales.
Alam MF; Cohen D; Dunstan F; Hughes D; Routledge P
Health Econ; 2018 Jan; 27(1):236-243. PubMed ID: 28685890
[TBL] [Abstract][Full Text] [Related]
3. Abolition of prescription charges in Wales: the impact on medicines use in those who used to pay.
Groves S; Cohen D; Alam MF; Dunstan FD; Routledge PA; Hughes DA; Myles S
Int J Pharm Pract; 2010 Dec; 18(6):332-40. PubMed ID: 21054593
[TBL] [Abstract][Full Text] [Related]
4. An investigation of prescription and over-the-counter supply of ophthalmic chloramphenicol in Wales in the 5 years following reclassification.
Du HC; John DN; Walker R
Int J Pharm Pract; 2014 Feb; 22(1):20-7. PubMed ID: 23590558
[TBL] [Abstract][Full Text] [Related]
5. The impact of co-payment increases on dispensings of government-subsidised medicines in Australia.
Hynd A; Roughead EE; Preen DB; Glover J; Bulsara M; Semmens J
Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1091-9. PubMed ID: 18942671
[TBL] [Abstract][Full Text] [Related]
6. The effects of user charges on the dispensing of prescription medicines: a survey of prescription charge payment in the Wellington region.
Jones N; Purdie G
N Z Med J; 1993 Jun; 106(957):225-6. PubMed ID: 8367079
[TBL] [Abstract][Full Text] [Related]
7. Assessing changes in third-party gross margin for a single community pharmacy.
Urick BY; Urmie JM; Doucette WR; McDonough RP
J Am Pharm Assoc (2003); 2014; 54(1):27-34. PubMed ID: 24362541
[TBL] [Abstract][Full Text] [Related]
8. From the city to the bush: increases in patient co-payments for medicines have impacted on medicine use across Australia.
Kemp A; Glover J; Preen DB; Bulsara M; Semmens J; Roughead EE
Aust Health Rev; 2013 Feb; 37(1):4-10. PubMed ID: 23157851
[TBL] [Abstract][Full Text] [Related]
9. Benchmarking the current dispensing rate of Welsh hospital pharmacies.
Hiom S; Roberts D; Hawksbee M; Burfield R; Francis M; Walker K; Lord S; Warner N
J Clin Pharm Ther; 2006 Aug; 31(4):357-62. PubMed ID: 16882105
[TBL] [Abstract][Full Text] [Related]
10. Impact of the reduction of the prescription charge in Wales on the prescribing of non-sedating antihistamines in primary care.
Dhippayom T; Walker R
Health Policy; 2008 Sep; 87(3):309-15. PubMed ID: 18325622
[TBL] [Abstract][Full Text] [Related]
11. Differences between prescribed and dispensed medications.
Gardner TL; Dovey SM; Tilyard MW; Gurr E
N Z Med J; 1996 Mar; 109(1017):69-72. PubMed ID: 8606821
[TBL] [Abstract][Full Text] [Related]
12. Copayments for prescription medicines on a public health insurance scheme in Ireland.
Sinnott SJ; Normand C; Byrne S; Woods N; Whelton H
Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):695-704. PubMed ID: 26696242
[TBL] [Abstract][Full Text] [Related]
13. Estimating a reasonable reimbursement for community pharmacies in third-party programs.
Carroll NV
Manag Care Interface; 1999 Feb; 12(2):73-6, 79-80. PubMed ID: 10346189
[TBL] [Abstract][Full Text] [Related]
14. What proportion of prescription items dispensed in community pharmacies are eligible for the New Medicine Service?
Wells KM; Boyd MJ; Thornley T; Boardman HF
BMC Health Serv Res; 2014 Mar; 14():115. PubMed ID: 24606863
[TBL] [Abstract][Full Text] [Related]
15. The association of insurance type with costs of dispensed drugs.
Mott DA; Kreling DH
Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015
[TBL] [Abstract][Full Text] [Related]
16. Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries.
Kennedy J; Morgan S
Clin Ther; 2009 Jan; 31(1):213-9. PubMed ID: 19243719
[TBL] [Abstract][Full Text] [Related]
17. Impact of final short-fill rule on Medicare Part D costs and long-term care pharmacy dispensing.
Bazalo G; Weiss RC
Consult Pharm; 2012 Apr; 27(4):269-73. PubMed ID: 22498986
[TBL] [Abstract][Full Text] [Related]
18. A comparison of pharmaceutical reimbursement agencies' processes and methods in France and Scotland.
Bending M; Hutton J; McGrath C
Int J Technol Assess Health Care; 2012 Apr; 28(2):187-94. PubMed ID: 22559763
[TBL] [Abstract][Full Text] [Related]
19. The prescribing of methadone and other opioids to addicts: national survey of GPs in England and Wales.
Strang J; Sheridan J; Hunt C; Kerr B; Gerada C; Pringle M
Br J Gen Pract; 2005 Jun; 55(515):444-51. PubMed ID: 15970068
[TBL] [Abstract][Full Text] [Related]
20. Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions.
Malone DC; Abarca J; Skrepnek GH; Murphy JE; Armstrong EP; Grizzle AJ; Rehfeld RA; Woosley RL
Med Care; 2007 May; 45(5):456-62. PubMed ID: 17446832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
